As a country we have heard and learned a lot about disease, and there are many opinions as to what works and what does not. Today specialist Dr. Lakhmir (Mink) Chawla joins us to explain the differences in bacterial and viral infections and how to make sense of an overload of information regarding infectious disease, including COVID-19. Using a technology called Seraph 100, created by ExThera Medical, there is help in treating COVID-19.
Dr. Lakhmir (Mink) Chawla
Dr. Lakhmir (Mink) Chawla is the Chairman of the Scientific Advisory Board and a board member for ExThera Medical. Dr. Chawla is also the Silver Creek Pharmaceuticals Chief Medical Officer and a clinical professor of medicine at the UCSD Medical Center and Veterans Affairs Medical Center.
Dr. Chawla was a professor of medicine at the George Washington University Medical Center in Washington, D.C., where he directed research efforts for the Division of Critical Care Medicine.
He previously headed the Division of Intensive Care Medicine at the Washington, D.C., Veterans Affairs Medical Center. With a focus on critical care and nephrology, Dr. Chawla has led and supported several grants and research projects centered onc acute kidney injury, renal disease, extracorporeal therapies, shock, and sepsis.